Thursday, December 17, 2015

A Look at the Portfolio of the California Stem Cell Agency

Look at the status of CIRM funding by disease
LOS ANGELES -- The California stem cell agency this morning presented a fresh breakdown of its spending by disease areas. The largest two components are in the neuro and cancer areas, which account for nearly half of the agency's portfolio. Sphere: Related Content

No comments:

Post a Comment